Effects of low dose growth hormone (GH) therapy [somatropin] on insulin sensitivity, metabolic profile, adipocyte IGF-I [insulin-like growth factor 1] and insulin signaling, intramyocellular lipids, and cortisol metabolism in obese women with polycystic ovary syndrome (PCOS)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Somatropin (Primary)
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 20 Feb 2013 Biomarkers information updated
- 21 Jul 2008 The actual initiation date for this trial has been identified as May 2008, as reported by ClinicalTrials.gov.
- 21 Jul 2008 The expected completion date for this trial has been extended from Sep 2009 to Aug 2010.